ArticleMolecular medicine (Cambridge, Mass.)2015

Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease.

Karen M Ashe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.